SOL Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,414
Closed -$269K 249
2018
Q3
$269K Buy
1,414
+75
+6% +$13.8K 0.07% 213
2018
Q2
$223K Buy
+1,339
New +$215K 0.06% 227

Other funds holding AGN

SOL Capital Management's AGN Position: Q4 2018 in Review

SOL Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,414 shares — an estimated $269K sold.

SOL Capital Management first reported a position in AGN in Q2 2018 and held it in 2 quarters. The position peaked at $269K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • SOL Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • SOL Capital Management sold 1,414 Allergan plc shares in Q4 2018, an estimated $269K.
  • SOL Capital Management first reported a position in Allergan plc in Q2 2018 and held it in 2 quarters.
  • SOL Capital Management's Allergan plc position peaked at $269K in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on SOL Capital Management's 13F filing for Q4 2018, filed 25 Jan 2019.